Chart from OrangeTee

Chart of the day: Mainland Chinese purchased the most non-landed homes in Singapore

District 10 was the most popular district amongst non-permanent resident foreigners.

This chart from OrangeTee shows the top five foreign buyers of non-landed homes from January to August 2022.

ALSO READ: Freehold commercial shophouse in Holland Village up for sale

The chart reveals that Mainland Chinese, both permanent residents and non-permanent residents, purchased the most non-landed homes at 932 units.

Foreigners from Malaysia bought the second most number of non-landed homes at 566 units, India at 324, and the USA at 203. Foreigners from Indonesia bought the least at 194.

According to Christine Sun, OrangeTee’s Senior Vice President of Research & Analytics, District 10 was the most popular district among foreign (non-PR) buyers. The most popular new project amongst non-PR was CanningHill Piers while the most popular resale project was Nouvel 18.

Follow the link for more news on

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.